ADVANCED IMMUNOMODULATING MULTI-COMPONENT SYSTEM
Mark Identification

ADVANCED IMMUNOMODULATING MULTI-COMPONENT SYSTEM

Serial Number

97006730

Filing Date

Sep 1, 2021

Trademark by

STATERA BIOPHARMA INC.

Classification Information

Pharmaceutical preparations and compounds for use in immune modulation, oncology, infectious diseases; pharmaceutical preparations for the treatment or prevention of immune-mediated diseases, Crohn's disease, multiple sclerosis, viral infections, HIV/AIDS, cancer, cell growth related disorders, cell proliferation related disorders, inflammatory diseases, ulcerative diseases, autoimmune diseases, autism, dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, stomach, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; anti-infectives; anti-inflammatories; vaccines; pharmaceutical preparations and compounds for reducing side effects in cancer treatment; pharmaceutical preparations and compounds for stimulating the immune system in an immuno-compromised patient; dietetic substances for medical purposes, namely, nutritional, vitamin and mineral supplements

Pharmaceuticals

Educational services, namely, conducting classes, seminars, conferences, and workshops and distributing printed course materials in conjunction therewith; providing on-line journals, namely, blogs in the medical, pharmaceutical and health fields

Education and Entertainment

Pharmaceutical and therapeutics research and development services for systemically delivered, locally active immune restorative conjugates, small molecules and peptides; research and development of systemically delivered, locally active immune restorative conjugates, small molecules and peptides in the pharmaceutical, therapeutics and biotechnology fields; research and product development of systemically delivered, locally active immune restorative conjugates, small molecules and peptides in the field of human therapeutics; research services using a platform of biological research tools and techniques for use in the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases and fibrotic diseases with systemically delivered, locally active immune restorative conjugates, small molecules and peptides; pharmaceutical product development of systemically delivered, locally active immune restorative conjugates, small molecules and peptides

Computer and Scientific